Publication | Open Access
COVID‐19 in patients with myasthenia gravis: Epidemiology and disease course
46
Citations
7
References
2021
Year
The risk of COVID-19 in MG patients seems to be no higher than that of the general population, regardless of immunosuppressive therapies. In our cohort, COVID-19 barely affected MG course.
| Year | Citations | |
|---|---|---|
Page 1
Page 1